Common medications used to treat substance use disorders like naltrexone, naloxone and methadone can be easy to confuse… and hard to understand even for the most seasoned professionals.
And, that’s just the beginning… Drug testing, poly-substance abuse, and co-occurring mental health problems create more obstacles.
Not only does award-winning researcher, author and board-certified clinical psychiatric pharmacist, David Dadiomov, PharmD, BCPP bring clarity to the latest research on Substance Use Disorders (SUD) and the role antidepressants, antipsychotics, psychedelics can play…
He’ll walk you through specific, easy-to-apply strategies on high-risk prescription opioid use, therapeutic drug monitoring, substance intoxication and withdrawal, treatment-resistant psychiatric conditions and more.
Whether you work in direct patient care or allied health settings… you’ll be able to apply his interventions to immediately see improved outcomes for your patients.
You’ll get unique and practical case studies and a simplified, comprehensive guide for medication and non-medication interventions for nearly most SUDs so you can quickly respond to signs of substance-use related emergencies and know how SUDs impact various health conditions… even for your most vulnerable patient populations.
Whether you’re a prescriber or not, you’ll get you need to stay up to speed on a rapidly changing field to improve your treatment outcomes and protect your license!
This self-study program consists of 2.25 clock hours of continuing education instruction. Credit requirements and approvals vary by country and local regulatory bodies. Please save the course outline, the certificate of completion you receive from the activity and contact your local regulatory organization to determine specific eligibility and requirements.
| File type | File name | Number of pages | |
|---|---|---|---|
| Manual - Advanced Psychopharmacology for Clinicians (1.7 MB) | 54 Pages | Available after Purchase | |
| Manual - Advanced Psychopharmacology for Clinicians - French (1.7 MB) | 54 Pages | Available after Purchase | |
| Manual - Advanced Psychopharmacology for Clinicians - Italian (1.7 MB) | 54 Pages | Available after Purchase | |
| Manual - Advanced Psychopharmacology for Clinicians - German (1.7 MB) | 54 Pages | Available after Purchase | |
| Manual - Advanced Psychopharmacology for Clinicians - Spanish (1.7 MB) | 54 Pages | Available after Purchase |
David Dadiomov, PharmD, BCPP, is an assistant professor of clinical pharmacy in the Titus Family Department of Clinical Pharmacy at the USC Mann School of Pharmacy and Pharmaceutical Sciences.
He holds board certification in psychiatric pharmacy and serves as the director of the PGY2 Psychiatric Pharmacy Residency Program. He has led, co-led and conducted extensive research on opioid use disorders among vulnerable populations, prevalence and distribution of high-risk prescription opioid use, therapeutic drug monitoring, treatment-resistant psychiatric conditions and more. Dr. Dadiomov practices as a clinical pharmacy specialist in addiction and psychiatry at the Complex Care Clinic of the Los Angeles County Department of Health Services, one of the largest of its kind in the United States.
Dr. Dadiomov’s teaching approach is case focused, practical for any clinical setting, interactive and evidence supported. His expertise has been shared with experienced clinicians, graduate students and advanced level students. Dr. Dadiomov is the recipient of multiple awards for clinical excellence, teaching and clinical innovation and has presented, authored and co-authored multiple peer-reviewed journal articles, book chapters, and scientific presentations.
Speaker Disclosures:
Access never expires for this product.
For a more detailed outline that includes times or durations of time, if needed, please contact cepesi@pesi.com
Psychopharmacology and Practical Application of Addiction Treatment
Treatment of Behavioral Health Disorders with Psychedelics
Satisfaction Guarantee
Your satisfaction is our goal and our guarantee. Concerns should be addressed to info@pesi.eu.
Please wait ...
